Kaftrio is a medicine used to treat patients aged 2 years and above who have cystic fibrosis, an inherited disease that has severe effects on the lungs, the digestive system and other organs. …

Elexacaftor/tezacaftor/ivacaftor, sold under the brand names Trikafta and Kaftrio, is a fixed-dose combination medication used to treat cystic fibrosis. [8][9] Elexacaftor/tezacaftor/ivacaftor is …

Kaftrio 是一种包含 Ivacaftor 、 Tezacaftor 和Elexacaftor（依伐卡托-特扎卡福特-依来卡泊）的三重疗法，用于治疗 囊性纤维化 （CF）。 该药物已获准用于12岁及以上的患者，这些患者要 …

Read about the triple combination therapy Kaftrio (known as Trikafta in the United States), which combines ivacaftor, tezacaftor and elexacaftor, and find out how it could help to treat people …

Kaftrio is a medicine used to treat patients aged 2 years and above who have cystic fibrosis, an inherited disease that has severe effects on the lungs, the digestive system and other organs. …

2023年11月23日 · Kaftrio is the latest of these CFTR modulator treatments and consists of a triple treatment combination of ivacaftor, tezacaftor, and elexacaftor. It’s a long term treatment for …

Kaftrio tablets are indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one F508del mutation in the …

临床数据显示， 在6-11岁CF患者中，Kaftrio+ivacaftor方案（Trikafta）治疗可显著改善肺功能、汗液氯化物、呼吸系统症状，安全性和耐受性与12岁及以上患者中的观察结果一致。 这些数据 …

2023年11月28日 · Kaftrio tablets are indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one …

What Kaftrio is and what it is used for. Kaftrio contains three active substances: ivacaftor, tezacaftor and elexacaftor. The medicine helps lung cells to work better in some patients with …